Abstract
Background: LDL-cholesterol is a key parameter for assessing the risk of atherosclerotic cardiovascular disease. Direct measurement of LDL-cholesterol is not always possible due to practical or financial reasons, making the use of calculation formulas essential for its evaluation. The aim of this study was to examine the applicability of four different formulas for calculating LDL-cholesterol compared to direct method in patients with serum triglyceride levels from 4.5 to 9.0 mmol/L in the population of Vojvodina.
Methods: The retrospective study included 272 subjects whose lipid status parameters were measured using standard laboratory methods between June 2022 and June 2023. The participants had serum triglyceride levels ranging from 4.5 and 9.0 mmol/L. LDL-cholesterol was determined by direct method (d-LDL-C) on Alinity c analyser (Abbott). Additionally, LDL-cholesterol levels were calculated for this population using the formulas proposed by Friedewald, Sampson, Anandaraja and Martin.
Results: In the studied population, the average age was 52 years and the median concentration of triglycerides was 5.48 (4.94-6.58) mmol/L. A statistically significant positive correlation was found between d-LDL-C and all calculated parameters (P<0.001). The lowest mean difference was observed between d-LDL-C and the Sampson formula (MD=-0.032). When comparing d-LDL-C and LDL-cholesterol values obtained by calculation, only the formula of Sampson et al. did not show a statistically significant difference (P=0.240).
Conclusion: In the studied population of patients with hypertriglyceridemia, the formula by Sampson et al. showed the best performance in comparison to the others tested and its application could be considered for the Vojvodina population.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.